Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Horm Metab Res ; 35(7): 427-33, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12931274

RESUMO

Autoimmune thyroid diseases are thought to be mediated by pro-inflammatory cytokines such as TNFalpha and IL-6. Serum levels of cytokines may indicate activity levels of immune functions. We investigated serum levels of IL-6 and of the soluble receptor of TNFalpha in patients with newly diagnosed onset of Graves' hyperthyroidism. The predominantly female group consisted of 39 patients, mean fT4 was 47.6 pg/ml (normal values 7.5=19.0 pg/ml). After diagnosis, all patients were treated with anti-thyroid drugs. Soluble Tumour Necrosis Factor Receptor I (TNF-RI) serum levels were found significantly increased (mean 3.7+/-1.3 ng/ml; p<0,01) compared to a matched group of apparent healthy individuals (mean sTNF-RI 1.8+/-0.5 ng/ml) and to a matched group of patients with treated Graves' disease (mean sTNF-RI 1.9+/-0.6 ng/ml). When IL-6 was assessed only 4 of the 39 patients exhibited increased serum levels. Our finding may indicate that sTNF-RI and possibly its ligand, TNFalpha, could play an important role in the onset of the acute stage of Graves' disease.


Assuntos
Doença de Graves/imunologia , Interleucina-6/imunologia , Receptores do Fator de Necrose Tumoral/imunologia , Adulto , Proteína C-Reativa/metabolismo , Feminino , Humanos , Técnicas Imunoenzimáticas , Interleucina-6/sangue , Masculino , Receptores do Fator de Necrose Tumoral/sangue , Análise de Regressão , Tireotropina/sangue , Tri-Iodotironina/sangue
3.
J Surg Oncol ; 77(3): 165-70, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11455552

RESUMO

BACKGROUND AND OBJECTIVES: The purpose of this study was to evaluate the feasibility of sentinel lymph node biopsy in breast cancer patients at our institution and to report the follow-up status of node-negative patients with removal of only the sentinel node. METHODS: A total of 247 breast cancer patients underwent sentinel node (SN) mapping between June of 1996 and September of 2000. The SN was identified by using a combination of vital blue dye and a radiolabeled colloid. RESULTS: A SN was identified in 227 of 247 patients (91.9%). One hundred forty-five were SN negative, 82 were SN positive. All SN-positive patients underwent axillary dissection of level I and II, whereas 83 patients with a negative SN had SN biopsy only. Median follow-up of these patients at 22 months revealed no axillary recurrence; the morbidity resulting from SN biopsy was negligible. CONCLUSIONS: Although the follow-up is very short, SN biopsy only in node-negative breast cancer patients had no negative impact on the axillary failure rate and resulted in negligible morbidity.


Assuntos
Neoplasias da Mama/patologia , Excisão de Linfonodo , Linfonodos/patologia , Biópsia de Linfonodo Sentinela , Adulto , Idoso , Idoso de 80 Anos ou mais , Axila , Neoplasias da Mama/cirurgia , Estudos de Viabilidade , Feminino , Seguimentos , Humanos , Linfonodos/diagnóstico por imagem , Pessoa de Meia-Idade , Prognóstico , Cintilografia
4.
Wien Klin Wochenschr ; 113(5-6): 204-7, 2001 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-11293951

RESUMO

Viruses are potential environmental factors in autoimmune disease. Some evidence suggests a relationship between enteroviral infection (especially Coxsackie B virus) and autoimmunity. We investigated 21 individuals with recent onset of Graves' hyperthyroidism in regard of (subclinical) enterovirus infection. Thyrotoxic symptoms had started about two months before blood sample collection. The patients were from Upper Austria and mainly female (17/21). Their mean free thyroxin levels in blood were twice the maximum normal value and the majority achieved a euthyroid state 1 1/2 years later, after antithyroid medication. We employed a nested PCR reaction with primers of the enterovirus genome on blood samples. All were negative for RNA of the enterovirus group. Coxsackie and related viruses were not identified as a trigger factor in autoimmune thyrotoxic disease.


Assuntos
Infecções por Enterovirus/complicações , Doença de Graves/imunologia , Doença de Graves/virologia , Adulto , Áustria/epidemiologia , Doenças Autoimunes/complicações , Doenças Autoimunes/virologia , Enterovirus Humano B/isolamento & purificação , Infecções por Enterovirus/epidemiologia , Infecções por Enterovirus/imunologia , Feminino , Glutamato Descarboxilase/imunologia , Doença de Graves/complicações , Humanos , Hipertireoidismo/virologia , Isoenzimas/imunologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Vigilância da População , RNA Viral/sangue , Estudos de Amostragem
5.
Nuklearmedizin ; 40(6): 221-7, 2001 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-11797511

RESUMO

AIM: The insufficiency fracture of the sacrum is often radiographically occult. Bone scintigraphy is a method of reference for the diagnosis; the results have been analysed retrospectively. METHODS: Bone scintigraphy was done on patients who, predominantly after minor trauma, suffered from lower back pain and whose radiographic findings were negative. RESULTS: During a 24 month period, a sacral insufficiency fracture was diagnosed in 102 patients. H-shaped hyperfixation of the tracer--described as typical--was present in only 19.6% of the cases. Tracer accumulation was found as follows: located uni/bilateral in the sacral wings (32.4%/6.9%), horizontal (27.4%) and half H-shaped (13.7%). In 85% of the cases there were further fractures with main localisations in the public bone, in the spine and the ribs. CONCLUSION: The insufficiency fracture of the sacrum as cause of lower back pain is not uncommon, especially in postmenopausal women with risk factors. Bone scintigraphy is not only an adequate procedure for the detection of often radiographically occult sacral fractures, but also an easy method to reveal the often concomitant fractures.


Assuntos
Fraturas de Estresse/diagnóstico por imagem , Dor Lombar/etiologia , Sacro/lesões , Fraturas da Coluna Vertebral/diagnóstico por imagem , Coluna Vertebral/diagnóstico por imagem , Fraturas de Estresse/complicações , Fraturas de Estresse/terapia , Humanos , Radiografia/instrumentação , Radiografia/métodos , Cintilografia , Estudos Retrospectivos , Fraturas da Coluna Vertebral/complicações , Fraturas da Coluna Vertebral/terapia , Distribuição Tecidual
6.
Nuklearmedizin ; 39(6): 166-73, 2000 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-11057408

RESUMO

UNLABELLED: AIM of the present retrospective study was to validate the clinical value of F-18-FDG PET imaging in lymphoma patients with a dual head camera modified for coincidence detection. Staging before and after oncological treatment was compared with a conservative diagnostic approach. METHODS: 48 patients (28 non-Hodgkin lymphoma, 20 Hodgkin's disease) received FDG-Hybrid-PET scans. Pretherapeutic staging was realized in 28 patients, 9 of them had control studies after they had completed therapy. Totally 29 persons were examined for post-therapeutic restaging. Computed tomography imaging and lymph node sonography was performed in all cases. Results were validated by clinical follow-up, in three cases a recidive was proven by biopsy. RESULTS: CT and ultrasound detected 77 lesions in 28 patients compared with 100 visualized by PET, but this difference in pretherapeutic staging did not reach significance at p > 0.05 by Fisher's t-test. Hybrid-PET obtained a sensitivity of 93%, a specificity of 79%, a positive of 82% and a negative predictive value of 92% for detection of residual disease. The values for CT + US were 87%, 64%, 72% and 88% respectively. CONCLUSION: FDG Hybrid-PET is as or even more accurate than standard morphologic diagnostic methods for prestaging in malignant lymphoma. Additionally, there is a substantial benefit for therapy monitoring of residual disease using coincidence detection PET with a 3/4-inch crystal gamma camera.


Assuntos
Fluordesoxiglucose F18 , Linfoma/diagnóstico por imagem , Linfoma/patologia , Estadiamento de Neoplasias/métodos , Compostos Radiofarmacêuticos , Tomografia Computadorizada de Emissão , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Doença de Hodgkin/diagnóstico por imagem , Doença de Hodgkin/patologia , Humanos , Linfoma não Hodgkin/diagnóstico por imagem , Linfoma não Hodgkin/patologia , Masculino , Pessoa de Meia-Idade , Neoplasia Residual/diagnóstico por imagem , Neoplasia Residual/patologia , Valor Preditivo dos Testes , Recidiva , Reprodutibilidade dos Testes , Estudos Retrospectivos , Tomografia Computadorizada por Raios X , Ultrassonografia
7.
Wien Klin Wochenschr ; 111(8): 329-32, 1999 Apr 23.
Artigo em Alemão | MEDLINE | ID: mdl-10378315

RESUMO

Primary lymphomas located in the thyroid gland are rare clinical findings. The therapy and the subsequent monitoring of the disease continue to be a subject of debate. We present the case of a 63-year-old female patient in whom a hemi-thyroidectomy was performed because of a growing goiter. Histological examination of the excised tissue revealed a large-cell B-lymphocytic lymphoma which extended to neighboring lymph nodes. The patient received chemotherapy which led to remission of disease for two years. The disease re-occurred in the remaining thyroid lobe. Subsequently, the patient was treated with involved-field radiation therapy which lead to long term remission. We conclude that total thyroidectomy should be considered in the treatment of lymphomas located in the thyroid gland.


Assuntos
Linfoma/cirurgia , Neoplasias da Glândula Tireoide/cirurgia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Citratos/uso terapêutico , Ciclofosfamida/uso terapêutico , Dexametasona/uso terapêutico , Epirubicina/uso terapêutico , Etoposídeo/uso terapêutico , Feminino , Gálio/uso terapêutico , Radioisótopos de Gálio , Humanos , Ifosfamida/uso terapêutico , Linfoma/tratamento farmacológico , Linfoma/patologia , Linfoma/radioterapia , Metotrexato/uso terapêutico , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Prednisolona/uso terapêutico , Compostos Radiofarmacêuticos , Indução de Remissão , Tecnécio/uso terapêutico , Tálio/uso terapêutico , Neoplasias da Glândula Tireoide/tratamento farmacológico , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/radioterapia , Tireoidectomia , Vincristina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...